GSK raises 2024 guidance after strong vaccine sales
In its first quarter, British company GSK said sales rose 10 per cent to £7.4bn but total operating profit fell 18 per cent to £1.49bn.
Full Article
GSK raises 2024 guidance after strong vaccine sales
City A.M.
0 shares
1 views
You might like
Related news coverage
GSK raises profit outlook on strong vaccine and HIV drug sales
Quarterly results beat expectations and signal strong start for pharma group
FT.com